WhitTier Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593K Hold
2,992
0.01% 377
2026
Q1
$505K Buy
2,992
+1,060
+55% +$181K 0.01% 376
2025
Q4
$331K Hold
1,932
0.01% 417
2025
Q3
$292K Sell
1,932
-300
-13% -$41K 0.01% 426
2025
Q2
$282K Sell
2,232
-370
-14% -$45.4K 0.01% 472
2025
Q1
$333K Sell
2,602
-113
-4% -$15.3K 0.01% 444
2024
Q4
$359K Hold
2,715
0.01% 413
2024
Q3
$395K Hold
2,715
0.01% 387
2024
Q2
$373K Sell
2,715
-356
-12% -$47.5K 0.01% 381
2024
Q1
$421K Hold
3,071
0.01% 364
2023
Q4
$417K Sell
3,071
-150
-5% -$18.3K 0.01% 366
2023
Q3
$394K Hold
3,221
0.01% 360
2023
Q2
$409K Hold
3,221
0.01% 362
2023
Q1
$416K Sell
3,221
-150
-4% -$19.6K 0.02% 359
2022
Q4
$443K Sell
3,371
-356
-10% -$46K 0.02% 355
2022
Q3
$436K Sell
3,727
-54,481
-94% -$6.77M 0.02% 353
2022
Q2
$6.85M Buy
58,208
+55,909
+2,432% +$6.64M 0.28% 84
2022
Q1
$300K Buy
2,299
+409
+22% +$53.3K 0.01% 414
2021
Q4
$288K Hold
1,890
0.01% 421
2021
Q3
$306K Hold
1,890
0.01% 398
2021
Q2
$309K Hold
1,890
0.01% 395
2021
Q1
$285K Hold
1,890
0.01% 397
2020
Q4
$286K Hold
1,890
0.01% 385
2020
Q3
$256K Sell
1,890
-600
-24% -$81.4K 0.01% 384
2020
Q2
$340K Sell
2,490
-165
-6% -$21K 0.02% 339
2020
Q1
$286K Sell
2,655
-105
-4% -$12.1K 0.02% 341
2019
Q4
$333K Hold
2,760
0.02% 352
2019
Q3
$275K Sell
2,760
-275
-9% -$28.8K 0.02% 369
2019
Q2
$331K Sell
3,035
-150
-5% -$16K 0.02% 342
2019
Q1
$356K Sell
3,185
-835
-21% -$91.6K 0.03% 325
2018
Q4
$388K Buy
4,020
+320
+9% +$34K 0.03% 293
2018
Q3
$451K Hold
3,700
0.03% 281
2018
Q2
$406K Sell
3,700
-75
-2% -$8.02K 0.03% 287
2018
Q1
$403K Sell
3,775
-525
-12% -$58.2K 0.03% 282
2017
Q4
$459K Buy
4,300
+10
+0.2% +$1.07K 0.04% 262
2017
Q3
$477K Sell
4,290
-150
-3% -$16K 0.04% 260
2017
Q2
$459K Sell
4,440
-225
-5% -$22.2K 0.04% 257
2017
Q1
$456K Sell
4,665
-84
-2% -$8.04K 0.05% 258
2016
Q4
$420K Buy
4,749
+3,699
+352% +$337K 0.04% 252
2016
Q3
$101K Hold
1,050
0.01% 423
2016
Q2
$90K Hold
1,050
0.01% 435
2016
Q1
$91K Hold
1,050
0.01% 434
2015
Q4
$118K Sell
1,050
-150
-13% -$16.3K 0.01% 403
2015
Q3
$121K Hold
1,200
0.01% 395
2015
Q2
$148K Sell
1,200
-210
-15% -$25.1K 0.02% 384
2015
Q1
$161K Hold
1,410
0.02% 378
2014
Q4
$143K Hold
1,410
0.02% 392
2014
Q3
$129K Hold
1,410
0.01% 394
2014
Q2
$121K Sell
1,410
-336
-19% -$26.5K 0.01% 415
2014
Q1
$138K Hold
1,746
0.02% 392
2013
Q4
$132K Sell
1,746
-195
-10% -$13.8K 0.02% 391
2013
Q3
$136K Hold
1,941
0.02% 369
2013
Q2
$112K Buy
+1,941
New +$112K 0.02% 392

Other funds holding IBB

WhitTier Trust Company's IBB Position: Q2 2026 in Review

WhitTier Trust Company held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,992 shares worth $593K. The position accounts for 0.01% of the portfolio, ranked #377.

WhitTier Trust Company first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.85M in Q2 2022. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • WhitTier Trust Company held 2,992 shares of iShares Biotechnology ETF worth $593K as of Q2 2026.
  • WhitTier Trust Company left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #377 holding.
  • WhitTier Trust Company first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's iShares Biotechnology ETF position peaked at $6.85M in Q2 2022.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.